Testing for Gestational Diabetes Mellitus in Australia

Nankervis, Alison; McIntyre, H. David; Moses, Robert G.; Ross, Glynis P.; Callaway, Leonie K.

doi:10.2337/dc12-2345

Cited by 91 publications

(127 citation statements)

References 6 publications

(5 reference statements)

Supporting

Mentioning

125

Contrasting

Order By: Relevance

“…According to the new ADIPS diagnostic criteria, a woman is diagnosed with GDM if at any stage during the pregnancy she had any one of the following glucose values: fasting ≥ 5.1 mmol/L, 1-h ≥ 10 mmol/L and 2-h ≥ 8.5 mmol/L. 4 IPH and The Wollongong Hospital (TWH) are the only two hospitals in the Wollongong area where deliveries can take place. The records of all the women who gave birth at IPH for the 12-month period from January 2012 to December 2012 were considered.…”

Section: Methodsmentioning

confidence: 99%

“…3 Subsequently, the method of testing and the diagnostic criteria have been adopted by the Australasian Diabetes in Pregnancy Society (ADIPS) 4 and endorsed, with a slight change in terminology, by the World Health Organization (WHO). 5 In the Wollongong area, obstetric care providers and pathologists have been using the new criteria since January 2010, and apart from some transition issues, this has been a standard practice since that time.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The prevalence of gestational diabetes mellitus: The accuracy of the NSW perinatal data collection based on a private hospital experience

Zheng

Moses²

2016

Aust NZ J Obst Gynaeco

Self Cite

View full text Add to dashboard Cite

Past studies have shown that the prevalence of gestational diabetes mellitus (GDM) has been underestimated, and this can have major implications for healthcare planning. With the changes in diagnostic criteria for GDM, we wanted to assess the accuracy of the diagnosis in a private hospital setting. Using data from the hospital's obstetric database, medical records and a private pathology provider, we established the true prevalence of GDM and compared it with the NSW Perinatal Data Collection. The recorded prevalence of 6.8% was well below the real value of 15.0%.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

The prevalence of gestational diabetes mellitus: The accuracy of the NSW perinatal data collection based on a private hospital experience

Zheng

Moses²

2016

Aust NZ J Obst Gynaeco

Self Cite

View full text Add to dashboard Cite

show abstract

“…One small study recently reported low rates of postpartum screening among Indigenous women in Far North Queensland [34]. This study is timely with recent changes to national diabetes screening guidelines [16], which have particular implications for Indigenous women. To our knowledge, this is the first study to compare rates of postpartum glucose screening among Indigenous and nonIndigenous women diagnosed with gestational diabetes.…”

Section: Introductionmentioning

confidence: 93%

“…Strong evidence about the risks associated with diabetes in pregnancy [8] has led to changes to international [2] and national [16] screening guidelines for gestational diabetes. The changes include: offering screening in early pregnancy for women at high risk of type 2 diabetes, in addition to 24-28 weeks as is currently recommended; separating 'probable' undiagnosed type 2 diabetes from gestational diabetes; and changing the diagnostic thresholds.…”

Section: Introductionmentioning

confidence: 99%

Low Rates of Postpartum Glucose Screening Among Indigenous and non-Indigenous Women in Australia with Gestational Diabetes

Chamberlain

McLean

Oats

et al. 2014

Matern Child Health J

View full text Add to dashboard Cite

Women with gestational diabetes have a high risk of type 2 diabetes postpartum, with Indigenous women particularly affected. This study reports postpartum diabetes screening rates among Indigenous and non-Indigenous women with gestational diabetes, in Far North Queensland, Australia. Retrospective study including 1,012 women with gestational diabetes giving birth at a regional hospital from 1/1/2004 to 31/12/2010. Data were linked between hospital records, midwives perinatal data, and laboratory results, then analysed using survival analysis and logistic regression. Indigenous women had significantly longer times to first oral glucose tolerance test (OGTT) [hazards ratio (HR) 0.62, 95 % confidence interval (CI) 0.48-0.79, p < 0.0001) and 'any' postpartum glucose test (HR 0.81, 95 % CI 0.67-0.98, p = 0.03], compared to non-Indigenous women. Postpartum screening rates among all women were low. However, early OGTT screening rates (<6 months) were significantly lower among Indigenous women (13.6 vs. 28.3 %, p < 0.0001), leading to a persistent gap in cumulative postpartum screening rates. By 3 years postpartum, cumulative rates of receiving an OGTT, were 24.6 % (95 % CI 19.9-30.2 %) and 34.1 % (95 % CI 30.6-38.0 %) among Indigenous and non-Indigenous women, respectively. Excluding OGTTs in previous periods, few women received OGTTs at 6-24 months (7.8 vs. 6.7 %) or 2-4 years (5.2 vs. 6.5 %), among Indigenous and non-Indigenous women, respectively. Low rates of postpartum diabetes screening demonstrate that essential 'ongoing management' and 'equity' criteria for population-based screening for gestational diabetes are not being met; particularly among Indigenous women, for whom recent guideline changes have specific implications. Strategies to improve postpartum screening after gestational diabetes are urgently needed.

show abstract

“…(17) The International Diabetes Federation (IDF), American College Obstetricians and Gynaecologists and the Australasian Diabetes in Pregnancy Society recommend universal screening unless a selective process based on risk is deemed more appropriate. (18,19) (20) The aims of this study were to assess compliance with risk based screening for GDM in a prospective international cohort of nulliparous women conducted in settings where risk factor based screening is normal practice. We hypothesised that there is a poor adherence to risk factor screening resulting in reduced diagnosis of GDM and missed opportunity to adequately treat and as a result prevent the adverse outcomes associated with GDM.…”

Section: Introductionmentioning

confidence: 99%

Compliance with National Institute of Health and Care Excellence risk-based screening for Gestational Diabetes Mellitus in nulliparous women

Murphy

McCarthy

Khashan

et al. 2016

European Journal of Obstetrics & Gynecology and Reproductiv

View full text Add to dashboard Cite

Testing for Gestational Diabetes Mellitus in Australia

Cited by 91 publications

References 6 publications

The prevalence of gestational diabetes mellitus: The accuracy of the NSW perinatal data collection based on a private hospital experience

The prevalence of gestational diabetes mellitus: The accuracy of the NSW perinatal data collection based on a private hospital experience

Low Rates of Postpartum Glucose Screening Among Indigenous and non-Indigenous Women in Australia with Gestational Diabetes

Compliance with National Institute of Health and Care Excellence risk-based screening for Gestational Diabetes Mellitus in nulliparous women

Contact Info

Product

Resources

About